Lymph Node Involvement in Ovarian Serous Tumors of Low Malignant Potential (Borderline Tumors) pathology, prognosis, and proposed classification McKenney,

Slides:



Advertisements
Similar presentations
An audit of Endometrial Pathology cases referred to NGOC Dr Paul Cross Consultant Cellular Pathologist Queen Elizabeth Hospital Gateshead.
Advertisements

Module 6: Clinical Stage and Grade. Introduction Stage and grade determine prognosis Staging reflects the clinical extent of the tumor Grading a tumor.
Breast Cancer. Introduction Most common female cancer Accounts for 32% of all female cancer 211,300 new cases yearly and rising 40,000 deaths yearly.
 DISCUSSION Number of resected lymph nodes in esophageal surgery has been previously discussed as for its probable impact on patients’ survival [4]. The.
Endometrial Cancer Surgical Staging (Role of Lymphadenectomy) Karl Podratz MD PhD FACS.
Slide Seminar Sami Shousha, MD, FRCPath Department of Histopathology, Charing Cross Hospital & Imperial College, London Amman, November 2013.
 - an important step in surgical staging for uterine cancer (FIGO 1988)  Stated as 
Sentinel Lymph Node Biopsy in Melanoma
Malignant Adenomyoepithelioma of the Breast with Lymph Node Metastasis
Is the BRAF V600E mutation useful as a predictor of preoperative risk in papillary thyroid cancer? The American Journal of Surgery.
A significant increase in the incidence of endometrial cancer. This increased incidence of endometrial cancer has been widely interpreted to be a result.
High-grade Prostatic Intraepithelial Neoplasia on Needle Biopsy Risk of Cancer on Repeat Biopsy Related to Number of Involved Cores and Morphologic Pattern.
Ji Young Lee, MD, PhD, David Marchetti, MD, M Steven Piver, MD Department of Obstetrics and Gynecology Sisters of Charity Hospital, Buffalo, NY The Clinical.
Ovary.
Role of Neck Dissection for Differentiated Thyroid CA Joint Hospital Surgical Grand Round NDH Dr. Alex TSANG.
Case Study 62 Kenneth Clark, MD. Question 1 This is a 32-year-old woman with progressive distortion of taste and smell. After seeing her primary care.
Ovarian Involvement by Metastatic Colorectal Adenocarcinoma Still a Diagnostic Challenge Michael R. Lewis, MD, Michael T. Deavers, MD, Elvio G. Silva,
Elshami M.Elamin, MD Medical Oncologist Central Care Cancer Center Wichita, KS, USA
THE SIGNIFICANCE OF HISTOLOGICAL SUBSTAGING IN CURATIVE RESECTED T3 COLORECTAL CANCER Karl Mrak & Jörg Tschmelitsch Department of Surgery, Barmherzige.
Department of pathology Prof:- Adiga. Student name :- Saeed Ayed saed Abdulrahman Awagi Alnami Muhannad Ali Asiri Faris.
Santa Monica 2006 IGCS - Interactive Session
UOG Journal Club: January 2013
BY DR. KHANSA IQBAL SENIOR REGISTRAR GYNAE UNIT-II.
Conservative Management of Borderline Ovarian Tumor Prof. Dr. Fuat Demirkıran I.U Cerrahpaşa School of Medicine. Department of OB&GYN Division Of Gynocol.
4% of all female cancers 25% of all gynecologic cancers life time risk: 1/70 ¾ advanced stage most lethal Epithelial Ovarian Cancer:
SYB Case 2 By: Amy. History 63 y/o female History of left breast infiltrating duct carcinoma s/p mastectomy in 1996 and chemotherapy ER negative, PR negative,
Are there benefits from chemotherapy to early endometrial cancer
Lymphadenectomy in Epithelial Ovarian Cancer
LUNG ADENOCARCINOMAS. CLINICOPATHOLOGICAL STUDY WITH RESPECT TO THE UPCOMING NEW CLASSIFICATION AND EGFR-KRAS MUTATION ANALYSIS IMPLICATIONS. First author:
Ductal Carcinoma In Situ Shahla Masood, M.D. Professor of Pathology University of Florida College of Medicine - Jacksonville Chief of Pathology and Laboratory.
Female reproductive system 89Chronic cervicitis 302Naboth cysts 141Cervical squamous cell carcinoma 45Endometrial hyperplasia 129Endometrial carcinoma.
Insert Program or Hospital Logo Introduction Melanoma is notoriously resistant to chemotherapy. While surgical resection and adjuvant chemotherapy can.
Metabolic Syndrome and Recurrence within the 21-Gene Recurrence Score Assay Risk Categories in Lymph Node Negative Breast Cancer Lakhani A et al. Proc.
Renal tumors Dr. Abdelaty Shawky Dr. Gehan Mohamed.
11th Biennial Meeting of the International Gynecologic Cancer Society 11th Biennial Meeting of the International Gynecologic Cancer Society Semih Gorgulu,
Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain.
Current Role of Partial Cystectomy: Are we scarifying patient ’ s survival Dr Eric Li Department of Surgery Pamela Youde Nethersole hospital.
TTF-1 POSITIVE THYROID-LIKE PAPILLARY WILMS’ TUMOR. M. Bisceglia (1), G. Lastilla (2), N. Santoro (3), F. De Leonardis (3), and C. Galliani (4). Department.
Training Program SLN Micrometastasis vs ITC Roderick R. Turner, MD Adjunct Member, JWCI.
First author: Roman Adina Co-author: Andone Sebastian
Principles of Surgical Oncology Done by : 428 surgery team surgery team.
ANNUAL SLIDE SEMINAR June Bratislava Slovakia B. Fredrik Petersson MD, PhD Department of Pathology, Karolinska University Hospital Stockholm.
Hodgkin lymphomas Monirath Hav, MD, PhD fellow Pathology Department Ghent University Hospital Adapted from WHO Classification of Tumours of Haematopoietic.
17 th century microscopes In The Name of God PARISA REZAEI,M.D.,AP.CP.
1 Differential Diagnosis of Neoplastic Pancreatic Cysts: The Role of EUS with Guided FNA E.M.Santo,Y.Ron,O.Barkay,Y.Kopelman,M.Leshno,S.Marmor Dep. of.
Breast Cancer. Breast cancer is a disease in which malignant cells form in the tissues of the breast – “National Breast Cancer Foundation” The American.
Ki-67 index cutoff value of 1% is a valuable prognostic biomarker for pulmonary carcinoids based on this large cohort. Our data also provide strong evidence.
Ovarian Tumors Epidemiology - Ranks below only carcinoma of the cervix and the endometrium. -Ovarian cancer accounts for 6% of all cancers in the female.
NODULAR MELANOCYTIC NEVI IN THE FIBROUS CAPSULE OF AXILLARY LYMPH NODE. REPORT OF A CASE. F. Tallarigo, I. Putrino, A.V. Filardo°, S. Squillaci°° Anatomia.
The Royal Marsden Solitary fibrous tumours The outcomes of 106 patients illustrating the unpredictable biological behaviour N Alexander, K Thway, JM Thomas,
Surgery of colorectal metastasis in the Optimox 1 study. A GERCOR Study. N. Perez-Staub, G. Lledo, F. Paye, B. Gayet, M. Flesch, A. Cervantes, A. Figer,
Anaplastic thyroid cancer based on ATA guideline for Management of Patients with ATC. Thyroid. 2012;22: R3 이정록.
Neoadjuvant treatment of borderline resectable and non-resectable pancreatic cancer V. Heinemann*, M. Haas & S. Boeck Annals of Oncology 24: 2484–2492,
Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer Anna Bill-Axelson, M.D., Lars Holmberg, M.D., Ph.D., Mirja Ruutu, M.D., Ph.D., Michael.
HE-4 TRIAL Prospective phase II trial on the prognostic and predictive value of HE-4 regression during neoadjuvant chemotherapy for advanced ovarian, Fallopian.
Should Elderly Patients Undergo Additional Surgery After Non-Curative Endoscopic Resection for Early Gastric Cancer? Long-Term Comparative Outcomes R3.
CLINICAL ASPECT OF GRADING AND STAGING Hanggoro Tri Rinonce, MD, PhD Department of Anatomical Pathology Faculty of Medicine, Gadjah Mada University.
Significance of Neoplastic Involvement of Margins Obtained by Endoscopic Mucosal Resection in Barrett’s Esophagus Ganapathy A. Prasad, M.D. Navtej S. Buttar,
The role of chemotherapy in Borderline ovarian tumors Ines Vasconcelos, MD/PhD Oncology Center Kurfurstendamm, Berlin - DE.
LECTURE 3, DISEASES OF THE JAW
Seromucinous Tumor of the Ovary
W. Scott Campbell, MBA, PhD James R. Campbell, MD
R. Michelle Sarin, MD Mentor: Jeffrey Fowler, MD
Discussion & Conclusion Predictives of Meningioma Grading
NIFTP Bijan Iraj,MD Assistant Professor of Internal Medicine and Endocrinology Department of Endocrinology and Metabolism Isfahan Medical.
EMT inducing transcription factor SIP1: a predictive biomarker of colorectal cancer survival and recurrence? A Patel, R Sreekumar, R Bhome, KA Moutasim,
Dr Amit Gupta Associate Professor Dept of Surgery
Tertiary cytoreductive surgery in recurrent epithelial ovarian cancer:
GOCS GRUPO ONCOLÓGICO COOPERATIVO DEL SUR
Presentation transcript:

Lymph Node Involvement in Ovarian Serous Tumors of Low Malignant Potential (Borderline Tumors) pathology, prognosis, and proposed classification McKenney, Jesse K. MD; Balzer, Bonnie L. MD, PhD; Longacre, Teri A. MD American Journal of Surgical Pathology. 30(5): , May 2006 Intern: 簡世杰

Serous borderline Tumours(SBT) Histological criteria for the diagnosis of serous borderline tumours. (WHO) 1. Epithelial hyperplasia in the form of stratification, tufting, cribriform and micropapilary arrangements 2. Atypia (usually mild to moderate) 3. Detached cell clusters 4. Variable and usually minimal mitotic activity 5. Absence of destructive stromal invasion

Introduction Ovarian serous tumors of low malignant potential (S-LMP) may be associated with lymph node involvement (LNI) in 21% to 29% of patients who undergo a formal lymph node sampling at the initial staging surgery Gynecol Oncol. 1991;42: Am J Surg Pathol. 2005;29:

Purpose Evaluate the specific histologic patterns of nodal involvement Criteria for classifying LNI into prognostic groups (Although criteria have been proposed for invasive and noninvasive implants in the peritoneum and outcome data have been linked to these subtypes.) nodal involvement by S-LMP may in some cases arise independent of the ovarian tumor via neoplastic transformation from preexisting endosalpingiosis. Am J Surg Pathol the definition and the relative prognostic and therapeutic implications?

Materials and Methods Database : Stanford University Medical Center Division of Surgical Pathology or the Stanford Pathology Consultation Service from the years 1958 to 1998 Patient Numbers : approximately 540 S-LMP. 74 patients who underwent a surgical staging procedure that included retrieval of lymph node. Classification : according to the current World Health Organization criteria into two types: typical S-LMP (serous borderline tumor) and S-LMP with micropapillary features (serous borderline tumor with micropapillary features). Lyon, France: IARCPress; 2003

Materials and Methods Stage : the International Federation of Gynecology and Obstetrics system Statistical analysis : Fisher exact test Significance leve was set at P<0.05 All tumors with micropapillary or cribriform features were classified on the basis of the modified Burks criteriamodified Burks criteria The presence of stromal microinvasion was determined using the criteria of Bell and Scullycriteria of Bell and Scully Ovarian autoimplants were not classified as stromal invasion. Extra-ovarian epithelial implants were classified as invasive, noninvasive, or indeterminate

Materials and Methods Lymph nodes were classified as positive or negative based on the presence or absence of involvement by S- LMP The positive lymph nodes were further evaluated for the following features: 1. Architectural pattern and degree of cytologic atypia 2. Mitotic figures 3. Presence of tumor in sinuses or parenchyma 4. Greatest linear dimension of epithelial aggregates without intervening lymphoid tissue (nodular aggregate) 5. Number of foci involved in an individual lymph node 6. Stroma reaction 7. Extranodal extension

Materials and Methods Four morphologic patterns were identified: 1. Individual cells, cell clusters, and simple papillae 2. Intraglandular aggregates 3. Cell with prominent cytoplasmic eosinophilia( “ eosinophilic cells ” ) 4. Micropapillary (criteria provided by Bell et al)

Materials and Methods disease status was defined as follows 1. Dead of disease(DOD) : patient died as a result of persistent, progressive, or recurrent serous disease 2. Alive with disease (AWD) : patient alive with clinical and/or radiographic evidence of persistent, progressive, or recurrent serous disease at last follow-up visit 3. Dead of intercurrent disease (DID), patient died of an unrelated cause with no clinical or radiographic evidence of persistent, progressive or recurrent serous disease 4. No evidence of disease (NED) : no clinical or radiographic evidence of persistent, progressive, or recurrent serous disease at last follow-up visit

Result no LNI or endo- salpingiosis only No significant different between 2 groups

Follow-up Status for S-LMP Patients With and Without Lymph Node Involvement (LNI)

Result Follow- up An additional 10 patients developed recurrent disease (5 with LNI and 5 without LNI) with an interval from initial surgery to recurrence ranging from 7 to 158 months (mean, 49 months; median, 35.5 months). Five of the patients with recurrent disease were alive with disease at last follow-up. One patient with stage IV disease and axillary lymph node involvement had persistent, but otherwise stable, disease at 11 months of follow-up.

Result Anatomic site of lymph node(total=31) 1. in pelvic (18; 58%) 2. mesenteric/omental (9; 29%) 3. paraaortic (8; 26%) 4. supradiaphragmatic (2; 6%) There was no correlation between anatomic site of involvement and overall or disease-free survival.

Cytologic & Histologic Patterns Cytologic patterns 1. Mild cytologic atypia  most cases 2. Moderate cytologic atypia  9 cases 3. Mitotic figures  7 cases(4/7 combined with moderate atypia) Individual cells, clusters of cells, and simple papillae individual cells, clusters of cells, and simple papillae (28 of 31; 90%) intraglandular pattern (21 of 31; 68%) prominent cytoplasmic eosinophilia (16 of 31; 52%) micropapillary architecture (5 of 31; 16%).

Individual cells, clusters of cells, and simple papillae

Individual Cells, Clusters of Cells, and Simple Papillae The most common pattern of LNI by S-LMP(28/31) 5 of these patients had stromal microinvasion and 4 had micropapillary architecture in the primary ovarian tumor. 16 patients with this pattern of LNI had noninvasive peritoneal implants, whereas 6 had invasive implants and 2 had implants that were indeterminate for invasion. Follow-up information : 2 DOD at 8 and 74 months, 3 AWD (11, 61, and 230 months), 15 NED, and 8 with no available follow-up data Disease-free survival versus LNI without this pattern : 75% and 50%, respectively (P=0.42).

Intraglandular pattern

Intraglandular Pattern 21/31 3 cases consisted entirely of the intraglandular pattern, one of which formed nodular aggregates with associated stromal reaction. 3 patients with intraglandular LNI had stromal microinvasion in the primary ovarian tumor and 3 had micropapillary architecture. All patients with intraglandular LNI had intraperitoneal implants (3 invasive and 18 noninvasive). Follow-up information : 11 NED and 3 AWD at 11, 38, and 230 months Disease-free survival versus LNI without this pattern : 79% and 71% respectively

Prominent Cytoplasmic Eosinophilia

16/31 3 patients had lymph nodes diffusely infiltrated by eosinophilic cells with a sinus and parenchymal distribution, one with nodular aggregates. 5 patients with LNI featuring eosinophilic cells had stromal microinvasion in the primary ovarian tumor 11 patients with eosinophilic cell LNI had peritoneal implants. 2 had invasive peritoneal implants  (no significance) Follow-up information : 6 NED ;2 NED following recurrence at 12 and 74 months, 1 AWD at 11 months, and 1 DOD. Disease-free survival versus LNI without this pattern : No significant difference

Micropapillary Architecture

5/31 The number of nodes involved : 2 to 11 (mean, 4.6), others :mean of 2.1 (range, 1 – 12) 3 of the 5 (60%) lymph nodes with micropapillary architecture also had an associated stromal reaction, compared with 2 of 26 (8%) without micropapillary architecture (P=0.02). 4 of the 5 (80%) micropapillary cases had nodular aggregates (size from 2 to 8 mm), whereas only 2 of the 26 (8%) nonmicropapillary cases formed a nodular aggregate (1 mm in size) (P<0.001). 3 (60%) were associated with endosalpingiosis, compared with 16 of 26 (62%) nonmicropapillary cases.

Micropapillary Architecture All 5 patients with micropapillary LNI had peritoneal implants. (2/5 invasive) Follow-up information : 2 AWD,1 NED at 87 months following an abdominal wall recurrence at 74 months, and 1 was NED with no evidence of recurrent disease at 77 months, 1 LFU Disease-free survival versus LNI without this pattern : 50% vs. 82% not reach statistical significance (P=0.22).

Stromal Response

Stromal Response in Lymph Node Involvement 5/31 (16%) cases with LNI had an associated stromal reaction. Each of the 5 cases with intranodal stromal reaction had nodular aggregates (P=0.0001) 3 had micropapillary architecture (P=0.02), and 1 had a diffuse “ eosinophilic cell ” pattern Follow-up information : 2 AWD, and 1 NED, 3 LFU Disease-free survival versus LNI without this pattern : 33% versus 68%(not significant?)

Extent and Location of Lymph Node Involvement Disease-free survival for patients with only one involved node versus patients with greater than one involved node was 73% and 80%, respectively. (one vs many) There was no significant difference in overall survival or disease-free survival in patients with diffuse LNI versus patients without diffuse LNI. Disease-free survival for LNI with parenchymal involvement compared with no parenchymal involvement was 69% and 77%, respectively (P=0.61).

Nodular aggregate

Extent and Location of Lymph Node Involvement Nodular aggregate : was defined as a collection of epithelium without intervening lymphoid tissue measuring greater than 1 mm in linear dimension Ps:diffuse LNI was characterized by epithelial cells of any morphologic pattern scattered throughout the lymph node (ie, not focal), but with intervening lymphoid tissue. Nodular aggregates were strongly associated with desmoplastic fibrous stromal reaction (P=0.001) and micropapillary architecture (P=0.02). Disease-free survival versus LNI without this pattern : 25% versus 87% (P=0.02)  significience

Endosalpingiosis

Association of Lymph Node Involvement With Endosalpingiosis 18/31(58%) versus 15/43(35%) (P=0.06) 4 mild cytologic atypia ; 1 moderate cytologic atypia no significant difference in overall survival for patients with and without LNI there was a trend for improved survival among patients with endosalpingiosis only (93%) compared with patients with LNI and endosalpingiosis (85%) and patients with LNI but no associated endosalpingiosis (56%).

YOKOHAMA COSMO WORLD

Disscussion lymph node status does not appear to be an independent prognostic factor for patient survival in patients with S-LMP. the presence of nodular aggregates is associated with a statistically significant adverse prognosis independent of histologic pattern. The relatively high incidence of LNI in this study (42%) ? LNI was commonly associated with peritoneal implants (87% of cases): (Leake et al) LNI was also associated with a higher incidence of disease recurrence ?  not meet statistical significance.

Histologic Patterns of S-LMP Lymph Node Involvement admixture of individual epithelial cells, clusters of l cells, and simple papillae frequently coexisted with an intraglandular pattern Distinguished from LNI by metastatic low grade carcinoma 1. Comparaticely low volume of epithelium 2. Minimal to at most moderate cytologic atypia 3. Rare mitotic figures

Histologic Patterns of S-LMP Lymph Node Involvement Primary ovarian S-LMP with micropapillary epithelial overgrowth are more often bilateral, exophytic, and associated with extraovarian implants than S-LMP without this appearance micropapillary architecture was strongly associated with disease progression over time and decreased overall survival on univariate analysis. Longacre et al the micropapillary pattern was more frequently associated with several other histologic features Ex: stromal reaction (60% vs. 12%), diffuse nodal involvement (60% vs. 38%), nodular aggregates (33% vs. 12%), and extranodal extension (20% vs. 0%).

Histologic Patterns of S-LMP Lymph Node Involvement This eosinophilic cell pattern of LNI was associated with stromal microinvasion in the primary ovarian tumor in almost one third of the cases in this series. the association between eosinophilic cell LNI and adverse outcome is not statistically significant Differential diagnosis : intranodal hyperplastic mesothelial cells  Immunohistochemistery : BER-EP4 ; calretinin P.S. S-LMP is characterized by cytoplasmic reactivity with Ber-EP4 but no nuclear calretinin expression

Nodular Aggregates of LNI Are Associated With Adverse Prognosis, Regardless of Histologic Pattern nodular aggregates of epithelium greater than 1 mm, without intervening lymphoid tissue,predicted a statistically significant : 1. decreased disease-free survival 2. strongly associated with micropapillary architecture and nodal stromal reaction 3. invasive peritoneal implants in 3 of 6 cases  should probably be classified separately from other patterns of LNI ? Nodular aggregates did not occur in association with any specific lymph node group in this study

Nodular Aggregates of LNI Are Associated With Adverse Prognosis, Regardless of Histologic Pattern In our experience, the presence of nodular aggregates is more commonly encountered in recurrent disease and delayed lymph node involvement than at initial presentation Nodular Aggregates should be regarded as a high- risk lesion ? transformation to low-grade serous carcinoma ?

At Least Some S-LMP May Arise Primarily in Foci of Endosalpingiosis identical K-ras mutations in S-LMP and adjacent benign m ü llerian inclusions. (Alvarez et al) support the concept that S-LMP may arise in endosalpingiosis in at least a subset of cases. a trend for decreased survival among patients without associated endosalpingiosis (not meet statistical significance) 1. endosalpingiosis only (93%) 2. LNI and endosalpingiosis (85%) 3. LNI but no associated endosalpingiosis (56%).

Conclusion no single histologic pattern of LNI is entirely predictive of adverse outcome nodular aggregates of S-LMP is associated with decreased disease-free survival independent of implant type. nodular aggregates more common in cases with a micropapillary pattern and an associated stromal reaction in the intranodal tumor. This high-risk pattern of LNI may be analogous to invasive peritoneal implants in terms of prognostic significance and deserves independent assessment in future studies of S-LMP.